Business
US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News
The US Food and Drug Administration approves Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and…
The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.
- The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
- However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
- Remdesivir will be sold…
Continue Reading
-
General20 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
Noosa News22 hours agoLogan City Council to pull out of federal government Climate Active program due to financial pressure, transparency concerns
-
Business23 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares
-
Noosa News19 hours agoCharlie the therapy dog reduces stress – Proctor